TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bohus BioTech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
36,442
|
38,442
|
16,896 |
| Financial expenses |
2,292
|
34
|
983 |
| Earnings before taxes |
-31,410
|
32,127
|
-64,486 |
| EBITDA |
-28,441
|
32,960
|
-44,798 |
| Total assets |
77,615
|
42,294
|
37,040 |
| Current assets |
58,211
|
30,325
|
30,759 |
| Current liabilities |
10,597
|
13,112
|
37,446 |
| Equity capital |
22,319
|
28,707
|
-38,328 |
| - share capital |
649
|
672
|
668 |
| Employees (average) |
30
|
29
|
39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
28.8%
|
67.9%
|
-103.5% |
| Turnover per employee |
1,215
|
1,326
|
433 |
| Profit as a percentage of turnover |
-86.2%
|
83.6%
|
-381.7% |
| Return on assets (ROA) |
-37.5%
|
76.0%
|
-171.4% |
| Current ratio |
549.3%
|
231.3%
|
82.1% |
| Return on equity (ROE) |
-140.7%
|
111.9%
|
168.2% |
| Change turnover |
-728
|
21,459
|
-42,082 |
| Change turnover % |
-2%
|
126%
|
-71% |
| Chg. No. of employees |
1
|
-10
|
-10 |
| Chg. No. of employees % |
3%
|
-26%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.